Clinical Trials Logo
  1. Home
  2. Pneumonia
  3. NCT06103981
  4. Details
NCT06103981 Clinical Trial

Acute Liver Injury in Patients With Pneumonia

Pneumonia Clinical Trial

Official title:
Acute Liver Injury in Patients With Pneumonia and Its Impact on Hospital Stay and Outcome

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06103981
Other study ID # Acute Liver Injury
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date December 1, 2023
Est. completion date March 10, 2025

Study information
Verified date October 2023
Source Assiut University
Contact Beshoy Yousef, MSc
Phone 01114761284
Email Beshoyyoussef18@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Acute liver injury (ALI) is defined as an acute derangement in liver function tests associated with liver-related coagulopathy, in the absence of underlying chronic liver disease. A subset progress to acute liver failure ,Acute liver failure represent a more severe liver injury results in hepatic encephalopathy

Description:

Acute liver injury is associated with a spectrum of haemostatic changes, including thrombocytopenia and reduced platelet function, reduced plasma levels of many coagulation factors such as factor (F)VII and increased levels of FVIII . Pneumonia is an acute inflammation of the lower respiratory tract. Lower respiratory tract infection is a major cause of mortality worldwide .Pneumonia is most common at the extremes of life. In adults, pneumonia can be broadly classified, on the basis of chest radiographic appearance, into lobar pneumonia, bronchopneumonia and pneumonia producing an interstitial pattern. There is lack of data regarding outcome and hospital stay in patients with pneumonia who develop acute liver injury.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 176
Est. completion date March 10, 2025
Est. primary completion date January 10, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 68 Years
Eligibility Inclusion Criteria: 1. Patients with pneumonia that developed Acute Liver Injury 2. Covid 19 pneumonia 3. Patients With acute liver injury only. Exclusion Criteria: 1. Cancer 2. Immunocompromised patients i.e HIV patients and patients who take immunosuppressive medications. 3. Patients who younger than 18 yrs old 4. pregnancy

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Acute Liver Injury
To evaluate the impact of acute liver injury in patients with pneumonia on hospital stay and outcome.

Locations
Country Name City State
Egypt Faculty Of Medicine Assuit

Sponsors (1)
Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Impact of Acute liver injury due to Pneumonia Analysis the impact of acute liver injury related to patients with pneumonia on hospital stay (measured by days spent in the hospital). From Hospital admission date to Two Months
Secondary Patients with Pneumonia only To evaluate the Patients with Pneumonia either developed acute liver injury or not, On Hospital Stay From Hospital admission date to Two Months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04244474 - Effect of Vitamin D Supplementation on Improvement of Pneumonic Children Phase 1/Phase 2
Completed NCT05815264 - Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above Phase 1
Recruiting NCT04589936 - Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care N/A
Completed NCT02905383 - The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital N/A
Terminated NCT03944551 - Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa N/A
Completed NCT06210737 - A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years Phase 4
Terminated NCT04660084 - Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT05702788 - Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19) Phase 2
Not yet recruiting NCT04171674 - Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation. N/A
Active, not recruiting NCT03140163 - Screening for Pneumonia: A Comparison of Ultra Low Dose Chest CT [ULD-CT] and Conventional Chest Radiography [CXR] N/A
Completed NCT02638649 - Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
Completed NCT02864420 - Hospitalization at Home: The Acute Care Home Hospital Program for Adults N/A
Recruiting NCT02515565 - Physiotherapy in Patients Hospitalized Due to Pneumonia. N/A
Completed NCT02105298 - Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study) N/A
Completed NCT01446926 - Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants Phase 1
Completed NCT01416519 - Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation N/A
Completed NCT01399723 - Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia Phase 3
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Terminated NCT02358642 - Drug to Prevent Pneumonia in the Tube Fed Phase 4